Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 92%
filed 2026-06-29
Item 5.02
The filing discloses the appointment of John P. Sharp as Interim Chief Financial Officer on June 25, 2026, replacing Quang X. Pham. While the section also includes a director resignation (Steven Zelenkofske) and board realignment, the principal disclosed action centers on the CFO appointment, which is material to investors as it affects the company's financial leadership. The detailed biography and compensation terms ($455/hour for up to 24 hours/week under a Master Services Agreement) underscore the significance of this executive appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
Troy W. Ingianni was appointed as Chief Financial Officer, Secretary and Treasurer of TransAct Technologies Inc., effective July 1, 2026, following the retirement of Steven A. DeMartino. Ingianni brings 25+ years of financial leadership experience and was appointed by the Board on June 26, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
Dr. Joe Xiao was appointed to the Board of Directors on June 23, 2026, and simultaneously appointed to three key committees (Audit, Compensation, and Nominating and Corporate Governance). The disclosure centers on the appointment action itself, not on compensation arrangements or departures. Board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-29
The filing discloses two executive changes under Item 5.02: the resignation of director Julianne Huh on June 24, 2026, and the appointment of Daniel Veikko Polvi as a director on June 29, 2026. While both events are present, the principal action emphasized in the disclosure is the Board's approval and appointment of Mr. Polvi, which includes detailed background on his qualifications and experience. The appointment of a new director to fill a vacancy is material to investors' assessment of board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-29
Item 5.02
Carol Juel has been appointed as Executive Vice President and Chief Executive Officer of Synchrony's Digital platform, succeeding retiring Bart Schaller. Florin Arghirescu has been promoted to EVP and Chief Technology Officer, and DJ Casto has been expanded to EVP, Chief People and Operations Officer. These appointments and promotions represent material changes to the company's executive leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-29
Item 5.02
Honeywell Aerospace appointed a new executive leadership team effective upon spin-off completion on June 29, 2026, including James Currier as President and CEO, Joshua Jepsen as CFO, John Donofrio as General Counsel and Secretary, and William Lautar as Vice President, Controller and Chief Accounting Officer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
Taylor Harris was appointed to the Board of Directors of Establishment Labs effective June 24, 2026, and concurrently appointed to the Audit Committee and Nominating and Corporate Governance Committee. Harris brings 25+ years of healthcare and medical technology experience, including prior CEO and CFO roles at major companies acquired for substantial valuations, making this a material governance event affecting board composition and expertise.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-29
NatWest Group announces the appointment of Erminia Johannson as an independent non-executive director effective 1 July 2026. This is a clear executive/board appointment disclosure. The announcement includes biographical details highlighting her extensive financial services experience, including prior roles as Group Head at Bank of Montreal and positions at Fidelity and CIBC, making this material to investors assessing board composition and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-29
EX-99.1
The press release announces the appointment of Ronen Assia as an independent director to Riskified's Board of Directors, effective June 25, 2026. This is a clear executive/governance appointment of a named individual to a board position. The disclosure identifies his background (Managing Partner at Team8, co-founder of eToro), qualifications, and expected contributions to the company's strategy, making it material to investors' assessment of board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
The filing discloses the appointment of Nicholas M. Maestas as Chief Financial Officer (principal financial officer and principal accounting officer) effective June 29, 2026, succeeding Svai Sanford. While the section also includes compensatory details (base salary of $500,000, 75% bonus target, and a 2,000,000-share option grant), the principal disclosed action is the appointment of a named executive to a principal officer role, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
The filing discloses the appointment of four Northfield Bancorp directors (John P. Connors, Jr., Timothy C. Harrison, Steven M. Klein, and Paul V. Stahlin) to Columbia Financial's board of directors, effective upon completion of the pending merger. This is a material executive appointment event tied to the merger transaction, with biographical details provided for each appointee and explicit reference to board size expansion from nine to thirteen directors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-26
Item 5.02
The filing discloses both the departure of Paul Krause as Chief Legal, Compliance and Corporate Affairs Officer and the appointment of Gayle Littleton to the same role, effective June 29, 2026. While both events occur, the principal action emphasized is the appointment of Littleton to fill the critical legal and compliance leadership position. The departure is framed as supporting an orderly transition, making the appointment the salient event. This is material as it involves a named executive officer in a key governance role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
The filing's primary disclosure is the appointment of Joseph R. Hinrichs as a director and expected future Chair of the Board, effective June 25, 2026. While the Item 5.02 section also covers compensatory arrangements (director compensation, CEO salary/equity increases, and adoption of new compensation plans), the salient event centers on the executive appointment. The appointment of an independent director with audit committee expertise to lead the board of a newly spun-off company is material to investors assessing governance and leadership continuity post-separation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
The filing discloses the appointment of Michael L. Hammer to the Board of Directors of URSB Bancorp, Inc. and its bank subsidiary, effective July 29, 2026, with assignment to the Audit Committee and Nominating/Corporate Governance Committee. This is a clear executive appointment under Item 5.02, and board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
Daniel Bendheim's appointment to Chief Executive Officer and President effective July 1, 2026 is the principal disclosed action. While the filing also details compensatory arrangements (employment agreement with $850,000 base salary, bonus, RSU grants), the core event is the executive appointment to the top leadership role. This is material to investors as CEO appointments significantly affect company direction and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-26
The filing announces multiple executive leadership appointments effective 1 July and 1 September 2026, including Jessica Farrell as President North America, Edgar Basto transitioning to Chief Enterprise Performance Officer, and Geraldine Slattery assuming expanded responsibilities as President Australia. While Brandon Craig's CEO appointment was previously announced on 18 March 2026, this disclosure announces the broader executive team restructuring and new appointments that would materially affect investor assessment of leadership capacity and organizational structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
The Board unanimously elected Anne DelSanto as an independent director effective July 1, 2026, increasing the Board size from six to seven members. Ms. DelSanto, with 30+ years of technology industry experience in cloud computing, SaaS, and AI, was also appointed to the Compensation Committee, strengthening the Board's expertise in areas aligned with the Company's strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
Jade Biosciences appointed Mark Eisner, M.D., M.P.H., to its Board of Directors as a Class I director and member of the Nominating and Corporate Governance Committee, effective June 25, 2026. Dr. Eisner brings 25+ years of clinical development and immunology leadership, including prior roles as Chief Medical Officer at Vir Biotechnology and FibroGen, and 11 years at Genentech/Roche, directly supporting the company's pipeline advancement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-26
Item 5.02
The filing discloses two executive changes: the departure of Chief Accounting Officer Yanina Grant-Huerta (effective July 17, 2026) and the appointment of Kevin G. Sarney as interim CFO and principal accounting officer (effective June 26, 2026). While both events are disclosed, the principal action centers on the appointment of Sarney to fill the critical CFO and principal accounting officer roles, making exec_appointment the most salient classification. The departure is secondary context to the appointment action.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
The filing discloses both the departure of CEO Josh Resnik and the appointment of Key Compton as President & Chief Executive Officer effective June 22, 2026. While both events occur, the principal disclosed action centers on the appointment of a new CEO—a material leadership change. The section also mentions Todd Aman's resignation as Chief Legal and Administrative Officer, but the CEO transition is the dominant event. The appointment of Compton, a board member since 2021 with three decades of technology experience, is the forward-looking material event that would affect investor assessment of the company's leadership and direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
The filing discloses the appointment of Joseph Samuels as a Class I director of Willow Lane Acquisition Corp. II effective June 22, 2026. The disclosure includes his background as founder and CEO of Islet Management and prior experience as a Partner at Och-Ziff Capital Management, along with standard representations regarding family relationships and related-party transactions. This is a clear executive appointment under Item 5.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
The filing discloses the appointment of Stephen Hood, the Company's Chief Executive Officer and President, to the Board of Directors as a Class II director effective immediately. This is a clear executive appointment under Item 5.02, where the principal disclosed action is a person taking on a board role. The appointment is material as it represents a change in corporate governance and board composition.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-26
EX-99.1
The exhibit discloses biographies of three "Newly Appointed Directors" to KNOREX LTD: Kai Zhong (corporate lawyer), Lu Liu (accounting/taxation expert), and Truong Vinh Phu Le (VP of Operations and founding member). The document explicitly identifies these individuals as newly appointed directors, which constitutes an executive appointment event. Director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
Darren E. Guidry was appointed President of Home Bancorp, Inc. effective July 1, 2026, representing a significant promotion from Chief Risk Officer. While the disclosure also mentions compensatory arrangements (salary increase to $384,000), the principal disclosed action centers on the appointment to a new executive role and the structural reorganization separating CEO and President functions. This is material to investors as it reflects a material change in the Company's leadership structure and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-26
Item 5.02
Fortrea appointed Jason F. Knoblauch as Chief Financial Officer effective July 6, 2026, succeeding Jill McConnell. Knoblauch's compensation package includes a base salary of $570,000, target bonus of 85%, an inducement award of $1,250,000, and equity grants totaling approximately $4,000,000 in RSUs and PSUs.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
The disclosure centers on the appointment of Matt Aune as Chief Financial Officer effective June 22, 2026. While the filing also includes compensatory details (base salary of $237,000 and a stock option grant of 1,500,000 shares), the principal disclosed action is the appointment of a named executive to a principal officer role. The compensation is ancillary to the appointment event itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-26
Item 5.02
Dara Bazzano was appointed as Robinhood's principal accounting officer effective June 25, 2026, a key executive role responsible for accounting, tax, financial operations, financial reporting, and internal control functions. While the disclosure also mentions that Shiv Verma ceased serving as principal accounting officer (retaining his CFO role), the principal disclosed action is the appointment of a new principal accounting officer with significant compensation details ($425,000 base salary, $1.54M equity target, $3.3M RSU grant, and $400,000 sign-on bonus), making this an executive appointment event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-26
Item 5.02
The filing discloses the appointment of Ms. Stephanie Wei-Ni Wen to the Board of Directors effective June 24, 2026. The Board explicitly states it believes her extensive transactional and legal experience qualifies her for the role. This is a clear director appointment under Item 5.02, which is material to investors as board composition affects governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-25
Item 5.02
The disclosure centers on the election of Doug Petno and Troy Rohrbaugh as Co-Presidents of JPMorgan Chase, with Petno becoming sole CEO of CIB and Rohrbaugh becoming CEO of CCB. While the filing also includes compensatory arrangements (equity awards) and a departure (Marianne Lake's retirement), the principal action disclosed is the appointment of two executives to major leadership roles. The succession planning context and the prominence given to the promotions support classification as exec_appointment rather than exec_compensation, though the compensation component is material and secondary.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-25
Item 8.01
The disclosure centers on the appointment of Carlos Adrian Gruebler as principal accounting officer and Vice President and Chief Accounting Officer of TMCC, effective June 29, 2026. While Brittany Baird's concurrent resignation is mentioned, the principal action disclosed is Gruebler's appointment to a key financial leadership role. The principal accounting officer is a material executive position affecting financial reporting oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Maria Milagros Paredes was appointed as Chief Financial Officer and Corporate Secretary of Lion Copper & Gold Corp. effective June 22, 2026, succeeding Lei Wang. The appointment includes material compensatory arrangements comprising a US$200,000 base salary, 2.5 million options with various vesting conditions, and severance protections.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
AeroVironment appointed William J. Lynn III to its Board of Directors, effective June 24, 2026. Lynn is a prominent defense industry executive with extensive government and national security experience, including prior service as U.S. Deputy Secretary of Defense and CEO of Leonardo DRS.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Archrock appointed Mohit Singh as Senior Vice President and Chief Financial Officer, effective July 6, 2026. Singh brings 25+ years of energy industry experience, including prior roles as CFO of Chesapeake Energy and senior leadership at BP and Goldman Sachs. The appointment includes substantial compensatory arrangements ($650,000 base salary, $2.3M annual equity target, $1.5M sign-on award).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-25
Item 5.02
The filing discloses two executive appointments: Gregory S. Patton was appointed Chief Executive Officer and Board member (promoted from CFO), and Michael Shelly was appointed Executive Vice President and Chief Financial Officer. While the disclosure also includes compensatory arrangements (employment agreements, equity awards, and PSU amendments), the principal disclosed action centers on these two appointments to key leadership roles. The appointment of a new CEO is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026. Mazelsky brings significant executive experience, including 14 years at IDEXX Laboratories where he served as President and CEO, and prior leadership roles at Philips and Agilent.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-25
Item 5.02
The company appointed Gilbert E. Nathan and Michael J. Wartell as independent directors and appointed Marie Persichetti as Chief Financial Officer effective August 1, 2026, replacing Jonathan Collins who resigned effective July 31, 2026. These appointments were made in accordance with the company's obligations under the Credit Agreement amendment and include detailed compensation and retention arrangements.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-25
Item 5.02
The filing discloses the appointment of Pratik Trivedi as President and CEO effective July 6, 2026, along with his appointment to the Board, which is the principal disclosed action. While the filing also covers Kieran O'Sullivan's transition to Executive Chairman (a departure from CEO), the substantive focus and forward-looking impact center on Trivedi's appointment to the top executive role, including detailed compensation terms ($675,000 base salary, $2.15M long-term incentive award, and change-in-control severance provisions). This is a material executive succession event affecting investor assessment of company leadership.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-25
EX-99.1
The exhibit is a Material Change Report (Form 51-102F3) announcing the appointment of Richard Pozzebon as Chief Financial Officer of Titan Mining Corporation, effective July 6, 2026. The appointment of a named executive officer to a C-suite position is a material governance event that would affect a reasonable investor's assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Two new directors, Laura Gentile and Marc Maurer, were appointed to the Board effective immediately following the 2026 annual meeting, increasing the Board size from 9 to 11 members pursuant to a previously disclosed Cooperation Agreement with Dennis J. "Chip" Wilson and related entities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-25
Item 7.01
Paul Kazarian has been appointed President and Principal Executive Officer of ASA Gold & Precious Metals Limited, representing a material change in the company's leadership. While the disclosure also mentions the departure of Axel Merk and Peter Maletis and the establishment of an interim investment committee, the principal action disclosed is the appointment of a new PEO, which is a significant governance event affecting investor assessment of company leadership and direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Boyd Gaming appointed two new independent directors, Stacia J. Andersen and George C. Roeth, to its Board of Directors effective June 22, 2026. Both appointees are experienced executives from major public companies (PetSmart, Abercrombie & Fitch, Central Garden and Pet, and Clorox) and qualify as independent under NYSE listing standards.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Peter Bell was elected to the Board of Directors effective June 23, 2026, and appointed as Chair of the Nominating and Corporate Governance Committee. The Board expanded from four to five members to accommodate this appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-25
The filing discloses the appointment of Ralph Venegas as Principal Financial Officer and Acting Chief Financial Officer of Laser Photonics, effective June 24, 2026. While the filing also mentions termination of the prior CFO arrangement with Roman Franklin/CFO Portal, the principal disclosed action centers on the appointment of a new CFO with detailed background information provided. This is a material executive appointment affecting the company's financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
The filing discloses three executive appointments effective June 18, 2026: Judah Korman as Chief Operating Officer, Zack Wilder as Chief Technology Officer, and Mordy Beyman as Vice President (later described as Executive Vice President in the press release). These are material leadership changes at a public company, with detailed biographical information and compensation arrangements disclosed under Item 5.02. The appointments are central to the company's stated strategic pivot toward AI-powered insurance products and agency roll-up operations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
The filing discloses the appointment of Steven N. Gordon as Chief Operating and Administrative Officer and Board member, and K. Harold Fletcher as Chief Legal and Strategy Officer and Corporate Secretary, both effective June 19, 2026. These are material executive appointments to senior leadership roles that would affect investor assessment of the company's governance and operational structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
NeoGenomics appointed Carolyn S. Starrett as a director to fill a newly created board vacancy, effective June 23, 2026. Ms. Starrett brings 25+ years of executive experience, including a decade as CEO of Flatiron Health and prior roles at Foundation Medicine and Boston Consulting Group, making this a material addition to the Board's composition and expertise.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-25
Item 5.02
Patrick Keenan was appointed as Chief Financial Officer of AlTi Global, Inc., effective July 1, 2026, promoted from Deputy CFO. The appointment follows the planned retirement of Michael Harrington and includes a compensation package of $375,000 salary plus $450,000 target bonus.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Ryan Schneider was appointed as a Class III director to Affirm's Board effective July 1, 2026, and appointed to the Audit Committee and Nominating and Governance Committee, bringing significant executive experience from his prior roles as CEO of Anywhere Real Estate and President of Card Business at Capital One.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Sudhanshu Priyadarshi was appointed as Chief Financial Officer and President, International, effective June 25, 2026. The appointment includes compensatory arrangements with a base salary of $900,000, target bonus of 115%, and equity awards totaling $7,000,000. Tom Fitzgerald's role as Interim CFO concluded with this appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-25
Item 5.02
The filing discloses both the resignation of Ms. Dandan Chen as Director and CEO and the election of Liao Xiu Ze as CEO. While both events occur, the principal disclosed action centers on the appointment of a new CEO—Liao Xiu Ze was elected to the CEO role in addition to his existing CFO, Treasurer, and Secretary positions. This is a material leadership transition affecting the company's chief executive officer position.
View raw filing on EDGAR →